L'Oréal S.A. (EPA:OR)

France flag France · Delayed Price · Currency is EUR
369.00
-1.20 (-0.32%)
Jun 17, 2025, 5:35 PM CET
-16.22%
Market Cap 197.16B
Revenue (ttm) 43.49B
Net Income (ttm) 6.41B
Shares Out 534.32M
EPS (ttm) 11.95
PE Ratio 30.88
Forward PE 28.10
Dividend 7.00 (1.90%)
Ex-Dividend Date May 5, 2025
Volume 256,562
Average Volume 329,013
Open 367.50
Previous Close 370.20
Day's Range 364.85 - 369.85
52-Week Range 316.30 - 447.15
Beta 0.85
RSI 44.31
Earnings Date Jul 29, 2025

About L'Oréal

L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide. The company operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty. It offers skincare, make-up, hair colourants, haircare, perfumes, and hygiene products. The company provides its products under the L’Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Stylenanda, Essie, Dark & Lovely, Mixa, L’Oréal Professionnel Paris, Kérastase, Redken, Matrix, Pureology, Lancôme, Yv... [Read more]

Founded 1909
Employees 94,397
Stock Exchange Euronext Paris
Ticker Symbol OR
Full Company Profile

Financial Performance

In 2024, L'Oréal's revenue was 43.49 billion, an increase of 5.60% compared to the previous year's 41.18 billion. Earnings were 6.41 billion, an increase of 3.63%.

Financial Statements

News

Nvidia's Generative AI To Fuel Hyper-Scalable 3D Rendering For L'Oréal

L’Oréal Groupe announced on Wednesday that it has partnered with Nvidia Corp . (NASDAQ: NVDA) to unlock AI’s potential in multiple aspects of beauty. Through this collaboration, L’Oréal and its partn...

6 days ago - Benzinga

Luxury skincare expansion: L’Oreal acquires majority stake in Medik8; announces 1 billion Euro deal

L'Oreal is set to acquire a majority stake in Medik8, a British skincare brand known for its vitamin A-focused products. This strategic move aims to bolster L'Oreal's presence in the thriving skincare...

8 days ago - The Times of India

L'Oreal buys British skincare brand Medik8

L'Oreal is to acquire British skincare brand Medik8, its owner, Britain-based private equity firm Inflexion, said on Monday, boosting the French cosmetics giant's offering in the fast-growing dermatol...

9 days ago - Reuters

L’Oreal sees Middle East and Southeast Asia as next growth engines as China slows: ‘Eventually demographics have to win’

Sales in SAPMENA, a region coined by L'Oreal that covers South Asia Pacific, Middle East, and North Africa, is the beauty brand's fastest growing region.

11 days ago - Fortune

Luxury earnings: Former LVMH exec highlights 2 things differentiating the winners

Ralph Lauren posted better-than-expected fiscal fourth quarter results on the top and bottom lines, but warns growth could slow as tariffs hit later this year. Pauline Brown, former LVMH North America...

26 days ago - Yahoo Finance

Take a tour inside L'Oreal's new American-based research and innovation center

CNBC's Charlotte Reed takes an exclusive tour of L'Oreal's new research and innovation center in Clark, New Jersey, as she learns about the latest technology developments at the world's largest cosmet...

5 weeks ago - CNBC International TV

L'Oreal Sales Rise After Boost From Luxe Unit

L'Oréal Chief Executive Nicolas Hieronimus said he is optimistic on the outlook for the global beauty market despite economic and geopolitical tensions.

2 months ago - WSJ

L'Oreal sales rise slightly, but US challenging

L'Oreal reported a rise in first-quarter sales on Thursday, beating expectations for slower growth, as strong demand for its creams and perfume in Europe helped counter challenging conditions in the U...

2 months ago - Reuters

Meet Françoise Bettencourt Meyers, the L'Oréal heiress worth about $80 billion

L'Oréal heiress Françoise Bettencourt Meyers is stepping down from the company's board of directors in 2025 after nearly 30 years.

3 months ago - Business Insider

Inside L'Oreal's $160 million research and innovation facility

The world's largest beauty company, L'Oreal, has invested $160 million to revamp its North America Research & Innovation Center, its largest investment in R&I in its 110 years history, located in Clar...

3 months ago - CNBC International TV

L'Oreal CEO plays down the impact of U.S. tariffs, says he's 'not overly concerned'

L'OrealCEO Nicolas Hieronimus said he is "not overly concerned" over the impact of White House tariffs on L'Oreal.

3 months ago - CNBC

L'Oreal recalls acne cream that may contain cancer-causing benzene

Makeup company L'Oréal S.A. issued a recall on all lots of acne cream Effaclar Duo due to concern that benzene, a known carcinogen, is in the product.

3 months ago - New York Post

L'Oreal CEO: Tariff wars are never good for consumers

L'Oreal CEO Nicolas Hieronimus discusses the U.S. market, tariffs, European competitiveness and Chinese demand in an exclusive interview at the firm's newly opened R&I facility in New Jersey.

3 months ago - CNBC International TV

L'Oreal CEO: Consumer demand must be stimulated by innovation

L'Oreal CEO Nicolas Hieronimus discusses the company's $160 million investment in its new U.S. R&I facility in an exclusive interview with CNBC.

3 months ago - CNBC International TV

L'Oreal CEO: Tariff wars are never good for consumers

L'Oreal CEO Nicolas Hieronimus discusses the U.S. market, tariffs, European competitiveness and Chinese demand in an exclusive interview at the firm's newly opened R&I facility in New Jersey.

3 months ago - CNBC

L'Oreal CEO: Consumer demand must be stimulated by innovation

L'Oreal CEO Nicolas Hieronimus discusses the company's $160 million investment in its new U.S. R&I facility in an exclusive interview with CNBC.

3 months ago - CNBC

A Rip Van Winkle Portfolio: Invest In These Companies And Forget You Did It

The Rip Van Winkle portfolio advocates for long-term, buy-and-hold investing in companies with competitive advantages, reasonable valuations, and strong financial performance. Alphabet, Meta, and Alib...

4 months ago - Seeking Alpha

Salon owner 'in limbo' over L'Oréal dispute delays

Rebecca Dowdeswell says it feels like there is no end in sight to her legal battle with the firm.

4 months ago - BBC